| Product Code: ETC10223110 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Colombia continued to rely on imports of prostate-specific antigen blood-based biomarkers, with key exporters being South Korea, China, Germany, the United Kingdom, and the United States of America. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry saw a negative compound annual growth rate (CAGR) of -6.0% from 2020 to 2024. Moreover, the growth rate from 2023 to 2024 experienced a significant decline of -48.46%, signaling challenges and potential shifts in the market dynamics for these crucial medical imports.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2021 & 2031F |
3.8 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2021 & 2031F |
4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about prostate cancer screening and early detection |
4.2.2 Rising prevalence of prostate cancer in Colombia |
4.2.3 Technological advancements in prostate-specific antigen blood-based biomarker testing |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and diagnostic services in certain regions of Colombia |
4.3.2 High cost associated with prostate-specific antigen blood-based biomarker testing |
4.3.3 Cultural stigma and reluctance among men to undergo prostate cancer screening |
5 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market, By Types |
6.1 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Application, 2021 - 2031F |
6.1.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Testing, 2021 - 2031F |
6.1.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Screening, 2021 - 2031F |
6.1.5 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Prognostic Testing, 2021 - 2031F |
6.1.6 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Monitoring, 2021 - 2031F |
6.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Serum PSA, 2021 - 2031F |
6.2.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Free PSA, 2021 - 2031F |
6.2.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Total PSA, 2021 - 2031F |
6.2.5 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Complex PSA, 2021 - 2031F |
6.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market, By Test Sensitivity |
6.3.1 Overview and Analysis |
6.3.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By High Sensitivity, 2021 - 2031F |
6.3.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Low Sensitivity, 2021 - 2031F |
6.3.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Specificity, 2021 - 2031F |
6.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market, By Distribution |
6.5.1 Overview and Analysis |
6.5.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Direct-to-Consumer, 2021 - 2031F |
6.5.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Import-Export Trade Statistics |
7.1 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Export to Major Countries |
7.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Imports from Major Countries |
8 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
8.1 Adoption rate of prostate-specific antigen blood-based biomarker testing in Colombia |
8.2 Number of healthcare facilities offering prostate-specific antigen blood-based biomarker testing |
8.3 Rate of increase in prostate cancer diagnosis at early stages |
8.4 Patient satisfaction with the process and accuracy of prostate-specific antigen blood-based biomarker testing |
8.5 Number of partnerships and collaborations between healthcare providers and diagnostic companies for promoting prostate cancer screening and testing in Colombia |
9 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
9.1 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2021 & 2031F |
9.4 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.5 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2021 & 2031F |
10 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
10.1 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2024 |
10.2 Colombia Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here